CN Stock MarketDetailed Quotes

300347 Hangzhou Tigermed Consulting

Watchlist
  • 64.00
  • +4.28+7.17%
Market Closed Oct 18 15:00 CST
55.36BMarket Cap49.00P/E (TTM)

Hangzhou Tigermed Consulting Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Hangzhou Tigermed Consulting Q3 2024 Estimates Date

Currency：CNYOct 29, 2024

Estimate YoY
Revenue
2.16B
+11.50%
EPS
0.59
--
Analyst Rating
Strong Buy

Oct 18, 2024

Hangzhou Tigermed Consulting Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 2.483B--
--2024/Q3-- / 2.053B--
--2024/Q21.698B / 2.066B--
--2024/Q11.660B / 2.216B--
--2023/Q41.734B / 1.874B--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 2.483B--
--2024/Q3-- / 2.053B--
--2024/Q21.698B / 2.066B--
--2024/Q11.660B / 2.216B--
--2023/Q41.734B / 1.874B--

Unlock Free Earnings Estimates

Hangzhou Tigermed Consulting Earnings Reports

  • Tiger Pharmaceuticals: 2024 Semi-Annual Report Summary

    Aug 28 12:00 ET

  • Tiger Pharmaceuticals: Semi-Annual Report 2024

    Aug 28 12:00 ET

  • Hangzhou Tigermed Consulting: 2024 First Quarter Report

    Apr 25 12:00 ET

  • Tiger Pharmaceuticals: 2023 Annual Report

    Mar 28 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Oct 18, 2024

    Strong Buy

    • Strong Buy

      84.62%

    • Buy

      15.39%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    % Chg

    No Data